Literature DB >> 17133448

Influence of gradual introduction of hydrophobic groups (stearic acid) in denatured atelocollagen on fibroblasts behavior in vitro.

P O Forest1, R Karoum, C H Gagnieu.   

Abstract

To prepare new biocompatible hydrophobic collagen films for medical devices, innovative collagen derivatives were synthesized by reaction of the lysyl amino groups of the alpha-chains with activated stearic acid. Different collagens having different substitution degrees were obtained and used to prepare films crosslinked with oxidized glycogen. Their physicochemical surface properties were evaluated, and in vitro assays were performed to analyze the behavior of fibroblasts in contact with the materials. The assays were performed with cells in adhesion and growth phases. The hydrophobic properties increased with the number of stearic acid introduced in the collagen but only in the range of 1-12 stearic acids per molecule. For higher modifications a decrease of hydrophoby was observed. All the films induced a decrease of cells growth and adhesion but without cytotoxicity. These effects were more pronounced for the collagen containing about eight stearic acid residues. Cells behavior on modified collagens films seems to be related to the chemical groups exposed on the surface of the films. Indeed, the surface chemistry directly influences the adsorption of adhesion proteins and modulates their conformation therefore modifying the cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133448     DOI: 10.1002/jbm.a.31042

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  1 in total

1.  Biological behaviour of an endothelial cell line (HPMEC) on vascular prostheses grafted with hydroxypropylgamma-cyclodextrine (HPgamma-CD) and hydroxypropylbeta-cyclodextrine (HPbeta-CD).

Authors:  N Blanchemain; F Chai; S Haulon; V Krump-Konvalinkova; M Traisnel; M Morcellet; B Martel; C J Kirkpatrick; H F Hildebrand
Journal:  J Mater Sci Mater Med       Date:  2008-02-12       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.